Tumor necrosis factor α: Posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells
Authors:
- 1 March 1996
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 166 (3) , 568-576
Abstract
The p53 protein directly regulates the expression of the WAF1 (wild-type p53-activated fragment 1) protein which is a cyclin-dependent kinase inhibitor (CDKI). DNA damaging agents such as ionizing or UV radiation, and some chemical agents induce WAF1 in wild-type p53 containing cells, thereby halting cell cycle progression. WAF1 expression is also induced through a p53-independent pathway. Tumor necrosis factor α (TNFα) is a cytotoxic/cytostatic compound for some human cancer cells. We examined a series of myeloid leukemic cell lines that expressed either no p53 (HL-60, K562) or mutant inactive p53 (KG-1, KCL22, THP-1, U937). The KG-1, HL-60, K562, and KCL22 myeloid leukemic cells increased their levels of WAF1 mRNA in the presence of TNFα. We focused on KG-1 cells to determine how TNFα modulated WAF1 expression. WAF1 mRNA increased in a dose-dependent manner in the cells after exposure to increasing concentrations of TNFα, and this increase occurred in the absence of new protein synthesis. An increase of WAF1 protein and a concominant decrease of cyclin-dependent kinase 2 activity also was found in KG-1 cells. Flow cytometry using 5-bromo-2′-deoxyuridine showed an increase in the proportion of TNFα-treated KG-1 cells in the G0/G1 phase of the cell cycle. TNFα enhanced the rate of WAF1 transcription only 1.4-fold in TNFα-treated KG-1 cells as compared to untreated cells. Notably, however, the half-life (t½) of WAF1 mRNA in TNFα-treated cells was 2.5 hours as compared to 0.5 hours in untreated cells. These results indicate that TNFα increases WAF1 levels at least in part via a posttranscriptional stabilization of the mRNA; and TNFα may mediate its cytostatic effects through WAF1 in some cell types.Keywords
This publication has 45 references indexed in Scilit:
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Tumor necrosis factor Characterization at the molecular, cellular and in vivo levelFEBS Letters, 1991
- Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation.Journal of Clinical Investigation, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolismBiochemical and Biophysical Research Communications, 1987
- A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradationCell, 1986
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.Journal of Experimental Medicine, 1986
- HEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin ExpressionScience, 1982
- Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)International Journal of Cancer, 1976